{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T04:31:08Z","timestamp":1774758668392,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ygyno.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,18]],"date-time":"2018-11-18T07:02:54Z","timestamp":1542524574000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer"],"prefix":"10.1016","volume":"152","author":[{"given":"Sonia","family":"Prader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Vollmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8477-506X","authenticated-orcid":false,"given":"Andreas","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beyhan","family":"Ataseven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Bommert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Uwe","family":"Waltering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Heikaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Albrecht","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Francesco","family":"Alesina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Traut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2018.11.001_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3322\/caac.21235","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.001_bb0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/gyno.2002.6736","article-title":"Micropapillary serous ovarian carcinoma: surgical management and clinical outcome","volume":"86","author":"Bristow","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.001_bb0025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2015.12.007","article-title":"Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV","volume":"140","author":"Ataseven","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2016.03.012","article-title":"Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer","volume":"141","author":"Prader","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.001_bb0040","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"Wimberger","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2017.07.124","article-title":"Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?","volume":"147","author":"Nasioudis","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.001_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gore.2016.05.006","article-title":"Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer","volume":"17","author":"LaFargue","year":"2016","journal-title":"Gynecol. Oncol. Rep."},{"issue":"7","key":"10.1016\/j.ygyno.2018.11.001_bb0060","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1245\/s10434-009-0486-5","article-title":"Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery","volume":"16","author":"Lim","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.09.001","article-title":"Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer","volume":"147","author":"Cowan","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.001_bb0070","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/IGC.0000000000000983","article-title":"Feasibility of transabdominal cardiophrenic lymphnode dissection in advanced ovarian cancer: initial experience at a tertiary center","volume":"27","author":"Garbi","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2012.12.023","article-title":"Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer","volume":"129","author":"Yoo","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.001_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/IGC.0b013e3181e833f5","article-title":"Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer","volume":"20","author":"Kolev","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2018.11.001_bb0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0009-9260(97)80034-7","article-title":"The significance of paracardiac lymph node enlargement in ovarian cancer","volume":"52","author":"Holloway","year":"1997","journal-title":"Clin. Radiol."},{"issue":"4","key":"10.1016\/j.ygyno.2018.11.001_bb0090","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1245\/s10434-015-5015-0","article-title":"Preoperative prediction of cardiophrenic lymph node metastasis in advanced ovarian cancer using computed tomography","volume":"23","author":"Kim","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2017.10.024","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: implications for survival","volume":"148","author":"Mert","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejca.2008.10.028","article-title":"Evaluation of lymph nodes with RECIST 1.1","volume":"45","author":"Schwartz","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2018.11.001_bb0105","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","article-title":"ESUR guidelines: ovarian cancer staging and follow-up","volume":"20","author":"Forstner","year":"2010","journal-title":"Eur. Radiol."},{"issue":"12","key":"10.1016\/j.ygyno.2018.11.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.ygyno.2018.11.001_bb0115","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","article-title":"FDG PET\/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread","volume":"126","author":"Hynninen","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2015.05.007","article-title":"The significance of paracardiac lymph-node enlargement in patients with newly diagnosed stage IIIC ovarian cancer","volume":"138","author":"Raban","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0130","first-page":"44","article-title":"Prediction of suboptimal cytoreduction of epithelial ovarian carcinoma by preoperative computed tomography","volume":"31","author":"Kebapci","year":"2010","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2018.11.001_bb0135","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1245\/s10434-009-0357-0","article-title":"Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis","volume":"16","author":"Harter","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2013.08.007","article-title":"Surgical practice of UK gynaecological oncologists in the treatment of primary advanced epithelial ovarian cancer (PAEOC): a questionnaire survey","volume":"131","author":"Barton","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.001_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/IGC.0b013e318205fb4f","article-title":"Ovarian cancer debulking surgery: a survey of practice in Australia and New Zealand","volume":"21","author":"Brand","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.001_bb0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2013.06.017","article-title":"Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182","volume":"130","author":"Rodriguez","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"32","key":"10.1016\/j.ygyno.2018.11.001_bb0155","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2016.69.7458","article-title":"How to select neoadjuvant chemotherapy or primary Debulking surgery in patients with stage IIIC or IV ovarian carcinoma","volume":"34","author":"Vergote","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.001_bb0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/IGC.0000000000001186","article-title":"The FIGO stage IVA versus IVB of ovarian cancer: prognostic value and predictive value for neoadjuvant chemotherapy","volume":"28","author":"Tajik","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.001_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2018.11.001_bb0170","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/IGC.0000000000000826","article-title":"Impact of abdominal wall metastases on prognosis in epithelial ovarian cancer","volume":"26","author":"Ataseven","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.11.001_bb0175","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.5500","article-title":"LION - lymphadenectomy in ovarian neoplasms. A prospective randomized AGO study group led Gynecologic Cancer Intergroup trial. AGO Ovar OP3\/ENGGOT-ov31","volume":"35","author":"Harter","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T08:52:22Z","timestamp":1546419142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818313635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0090825818313635"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}